Trademark: BEXIGNUS 2300845
Word
BEXIGNUS
ID
2300845
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
12 August 2022
Registration Date
12 August 2022
Renewal Date
12 August 2032
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceuticals; medical preparations; veterinary preparations; sanitary preparations for medical purposes; pharmaceutical preparations and substances for the treatment of cancer; tumor suppressing agents; antineoplastics; anti-cancer preparations; compounds for treating cancer; antibodies; biological preparations for medical purposes; adjuvants for medical purposes; vaccine adjuvants; anti-neoplastic preparations of chemical origin; anti-neoplastic preparations of microbial origin; antigens; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical use; immunomodulators; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of disorders of the immune system; serotherapeutic medicines; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for use in hematology.
Pharmaceuticals; medical preparations; veterinary preparations; sanitary preparations for medical purposes; pharmaceutical preparations and substances for the treatment of cancer; tumor suppressing agents; antineoplastics; anti-cancer preparations; compounds for treating cancer; antibodies; biological preparations for medical purposes; adjuvants for medical purposes; vaccine adjuvants; anti-neoplastic preparations of chemical origin; anti-neoplastic preparations of microbial origin; antigens; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical use; immunomodulators; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of disorders of the immune system; serotherapeutic medicines; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for use in hematology.